Trial intelligence / Profile preview

OxLith short-term lithium effects in bipolar mood instability

ISRCTN91624955Phase 4Completed

Sponsor
University of Oxford
Start
Apr 2015
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01

Overview

Phase 4, randomised trial in bipolar disorder (BD) comparing Lithium with Placebo (2 arms). Primary endpoint: Reduction in mood instability. Started Apr 2015; status: completed.

02

Drugs

lithium
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on ISRCTN91624955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN91624955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call